ArticleBiomedicines2022

A Rationale for the Activity of Bone Target Therapy and Tyrosine Kinase Inhibitor Combination in Giant Cell Tumor of Bone and Desmoplastic Fibroma: Translational Evidences.

Alessandro De Vita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.